NCT03930719View on ClinicalTrials.gov

Post-stroke Delirium Screening

CompletedOBSERVATIONAL
Enrollment

141

Participants

Timeline

Start Date

April 22, 2019

Primary Completion Date

July 21, 2019

Study Completion Date

August 31, 2019

Conditions
DeliriumIschemic StrokeTransient Ischemic Attack
Interventions
DIAGNOSTIC_TEST

Stroke screening tools

"Patients are evaluated for the presence of PSD using DSM-5 criteria (gold standard). Established delirium detection tools are evaluated for their diagnostic accuracy compared to the gold standard."

Trial Locations (1)

17475

Department of Neurology, Greifswald

All Listed Sponsors
lead

University Medicine Greifswald

OTHER

NCT03930719 - Post-stroke Delirium Screening | Biotech Hunter | Biotech Hunter